vue microscopique de cellules

TAP_DLB Project 2023 - 2025

Post-doctoral grant

Dementia with Lewy bodies (DLB) is a neurodegenerative disease with no known treatment currently, caused by the pathological accumulation of a protein naturally present in the brain in its soluble form. This project's research involves analysing the brains of primates that have been injected with Lewy bodies extracted from the brains of deceased patients. This analysis is the final stage before a primate model of DLB can be developed, essential both to the understanding of this disease and the development of therapeutic solutions.

Research carried out by the Physiopathology of Proteinopathies team of the Neurodegenerative Diseases Institute of the Bordeaux university hospital, under the direction of Erwan Bezard, INSERM Research Director.

The research team has already performed a comparative study of primate brains with DLB, Parkinson's and multiple-system atrophy, which identified avenues for future research that are both common and specific to each of the three synucleinopathies (diseases characterised by the abnormal accumulation of synuclein proteins, a shared feature of these three illnesses). This study strengthens the possibility of offering multiple treatment strategies for DLB.

Download the publications

Sci_Advances_NHP_2025_time_course (pdf, 11.05 MB)

npj_Parkinsons_Disease_DLB_2023 (pdf, 4.26 MB)